P. Rieber

5.4k total citations · 1 hit paper
36 papers, 4.3k citations indexed

About

P. Rieber is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, P. Rieber has authored 36 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in P. Rieber's work include T-cell and B-cell Immunology (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Immunotherapy and Immune Responses (8 papers). P. Rieber is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Immunotherapy and Immune Responses (8 papers). P. Rieber collaborates with scholars based in Germany, United States and Croatia. P. Rieber's co-authors include Ralf Schreck, Patrick A. Baeuerle, Gert Riethmüller, B. Dörken, Henning Stein, Ronny Schmidt, A. E. G. Kr. von dem Borne, Werner J. Pichler, G. Heberer and Ş. Ş. Alkan and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

P. Rieber

35 papers receiving 4.2k citations

Hit Papers

Reactive oxygen intermediates as apparently widely used m... 1991 2026 2002 2014 1991 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Rieber Germany 15 1.8k 1.5k 718 494 353 36 4.3k
Hitoshi Ohmori Japan 37 2.0k 1.1× 1.8k 1.2× 604 0.8× 431 0.9× 627 1.8× 207 5.1k
Sho Yoshida Japan 36 1.5k 0.8× 1.5k 1.0× 312 0.4× 1.2k 2.4× 350 1.0× 257 5.4k
Izumi Nakashima Japan 38 2.0k 1.1× 1.6k 1.1× 241 0.3× 445 0.9× 555 1.6× 192 4.7k
Shingo Tsuji Japan 39 2.4k 1.3× 1.0k 0.6× 779 1.1× 413 0.8× 920 2.6× 154 6.9k
Mariano Sánchez Crespo Spain 38 1.4k 0.8× 1.3k 0.8× 302 0.4× 481 1.0× 213 0.6× 140 4.0k
Charles Kunsch United States 24 2.2k 1.2× 1.2k 0.7× 761 1.1× 354 0.7× 399 1.1× 35 4.3k
Karl M. Stuhlmeier Austria 29 1.5k 0.9× 1.2k 0.8× 465 0.6× 373 0.8× 336 1.0× 60 4.2k
Kikuo Onozaki Japan 35 2.1k 1.1× 1.8k 1.2× 385 0.5× 380 0.8× 613 1.7× 169 5.0k
Heinfried H. Radeke Germany 43 2.7k 1.5× 2.0k 1.3× 616 0.9× 490 1.0× 576 1.6× 130 6.2k
Martha K. Cathcart United States 39 1.4k 0.8× 2.1k 1.3× 301 0.4× 589 1.2× 632 1.8× 80 4.6k

Countries citing papers authored by P. Rieber

Since Specialization
Citations

This map shows the geographic impact of P. Rieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Rieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Rieber more than expected).

Fields of papers citing papers by P. Rieber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Rieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Rieber. The network helps show where P. Rieber may publish in the future.

Co-authorship network of co-authors of P. Rieber

This figure shows the co-authorship network connecting the top 25 collaborators of P. Rieber. A scholar is included among the top collaborators of P. Rieber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Rieber. P. Rieber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qin, et al.. (2012). Monoclonal anti-CD4 antibody MT310 binds HIV-1 gp120 gp120 binding site on CD4. Tsinghua Science & Technology. 6(3). 257–259. 1 indexed citations
2.
Meye, Axel, Susanne Fuessel, Stefan Zastrow, et al.. (2006). Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Results of a phase I clinical trial. Journal of Clinical Oncology. 24(18_suppl). 2551–2551. 2 indexed citations
3.
Fricke, Harald, Johannes Hartmann, Thomas Sitter, et al.. (1996). Continuous ambulatory peritoneal dialysis impairs T lymphocyte selection in the peritoneum. Kidney International. 49(5). 1386–1395. 12 indexed citations
6.
Jonker, Margreet, Koon Y. Pak, Sarah Tam, et al.. (1993). In vivotreatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees. Clinical & Experimental Immunology. 93(3). 301–307. 15 indexed citations
7.
Yi, Qing, Ritva Pirskanen, G. Matell, et al.. (1993). Clinical Improvement of Myasthenia Gravis by Treatment with a Chimeric Anti‐CD4 Monoclonal Antibody. Annals of the New York Academy of Sciences. 681(1). 552–555. 11 indexed citations
8.
Liang, Shaohong, P. Rieber, Marie Prewett, et al.. (1991). Anti-idiotypic Antibodies Against Anti-CD4 Antibodies MT151 and OKT4A. Viral Immunology. 4(2). 83–90.
9.
Hahn, Jae W., Hans‐Jochem Kolb, Michael Schumm, et al.. (1991). Immunological characterization of canine hematopoietic progenitor cells. Annals of Hematology. 63(4). 223–226. 11 indexed citations
10.
Kolb, Hans‐Jochem, Ernst Holler, Jae W. Hahn, et al.. (1991). Functional characterization of canine lymphocyte subsets. Annals of Hematology. 63(1). 49–53. 7 indexed citations
11.
Walker, Christoph, Christian Herzog, P. Rieber, et al.. (1989). Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells. Journal of Autoimmunity. 2(5). 643–649. 23 indexed citations
12.
Knapp, W., et al.. (1989). CD antigens 1989. Blood. 74(4). 1448–1450. 87 indexed citations
13.
Herzog, Christian, Christoph Walker, Wolfgang Müller, et al.. (1989). Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. Journal of Autoimmunity. 2(5). 627–642. 110 indexed citations
14.
Emmrich, Frank, P. Rieber, R. Kurrle, & Klaus Eichmann. (1988). Selective stimulation of human t lymphocyte subsets by heteroconjugates of antibodies to the t cell receptor and to subset‐specific differentiation antigens. European Journal of Immunology. 18(4). 645–648. 15 indexed citations
15.
Endl, Josef, et al.. (1987). A new ELISA-based assay for quantitation of human T-lymphocyte subpopulations. Journal of Immunological Methods. 102(1). 77–83. 1 indexed citations
16.
Haas, R., et al.. (1986). Acquired immune haemolysis by anti a 1 antibody following bone marrow transplantation. Annals of Hematology. 53(5). 401–404. 6 indexed citations
17.
Göttlinger, Heinrich G., P. Rieber, J. M. Gokel, K.J. Lohe, & Gert Riethmüller. (1985). Infiltrating mononuclear cells in human breast carcinoma: Predominance of T4+ monocytic cells in the tumor stroma. International Journal of Cancer. 35(2). 199–205. 69 indexed citations
18.
Kaudewitz, Peter, et al.. (1984). Cells Reactive with Anti‐T‐Cell Monoclonal Antibodies in Malignant Cutaneous B‐Cell Lymphomas and Pseudolymphomas. The Journal of Dermatologic Surgery and Oncology. 10(4). 313–314. 4 indexed citations
19.
Rieber, P., Jürgen Lohmeyer, Dolores J. Schendel, & Gert Riethmüller. (1981). Human T Cell Differentiation Antigens Characterizing a Cytotoxic/Suppressor T Cell Subset. Hybridoma. 1(1). 59–69. 27 indexed citations
20.
Lohmeyer, Jürgen, P. Rieber, Helmut E. Feucht, et al.. (1981). A subset of human natural killer cells isolated and characterized by monoclonal antibodies. European Journal of Immunology. 11(12). 997–1001. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026